- Published
- 20 May 2020
- Letter
Clinical course and risk factors for mortality of COVID-19 patients with pre-existing cirrhosis: a multicentre cohort study
- Authors
-
- Source
- Gut
Abstract
In this study we provide the first report of the characteristics, comorbidities,
laboratory and x-ray findings, and clinical outcomes in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-infected patients with pre-existing liver cirrhosis. The cause of death in most patients was respiratory failure rather than progression of liver disease. Lower numbers of blood lymphocytes and platelets, and higher bilirubin levels might represent indicators of poor outcome in this patient population.
Rights
This article is made freely available for use in accordance with BMJ's website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.
Cite as
Qi, X., Liu, Y., Wang, J., Fallowfield, J., Wang, J., Li, X., Shi, J., Pan, H., Zou, S., Zhang, H., Chen, Z., Li, F., Luo, Y., Mei, M., Liu, H., Wang, Z., Li, J., Yang, H., Xiang, H., Li, X., Liu, T., Zheng, M., Liu, C., Huang, Y., Xu, D., Li, X., Kang, N., He, Q., Gu, Y., Zhang, G., Shao, C., Liu, D., Zhang, L., Li, X., Kawada, N., Jiang, Z., Wang, F., Xiong, B., Takehara, T. & Rockey, D. 2020, 'Clinical course and risk factors for mortality of COVID-19 patients with pre-existing cirrhosis: a multicentre cohort study', Gut, 70(2), pp. 433-436. https://doi.org/10.1136/gutjnl-2020-321666